We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
Cap. Flow
-$5.86B
Cap. Flow %
-7.4%
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231

Top Buys

Rank Stock Value
1
SYY icon
Sysco
SYY
+$273M
2
WM icon
Waste Management
WM
+$168M
3
LOW icon
Lowe's Companies
LOW
+$160M
4
PNC icon
PNC Financial Services
PNC
+$154M
5
UL icon
Unilever
UL
+$122M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$548M
2
AAPL icon
Apple
AAPL
+$372M
3
CSX icon
CSX Corp
CSX
+$369M
4
INFY icon
Infosys
INFY
+$238M
5
KMB icon
Kimberly-Clark
KMB
+$235M

Sector Composition

Rank Sector Weight
1 Technology 21.16%
2 Healthcare 14.65%
3 Financials 13.08%
4 Industrials 9.66%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPXU icon
1826
ProShares UltraPro Short S&P 500
SPXU
$394M
0
SRDX
1827
DELISTED
Surmodics
SRDX
-1,542
Closed -$59K
STRA icon
1828
Strategic Education
STRA
$1.89B
-227
Closed -$20K
STRL icon
1829
Sterling Infrastructure
STRL
$16.4B
-6,044
Closed -$85K
SUPN icon
1830
Supernus Pharmaceuticals
SUPN
$2.73B
-2,461
Closed -$51K
SVXY icon
1831
ProShares Short VIX Short-Term Futures ETF
SVXY
$205M
$0 ﹤0.01%
+2
New +$39
SWK icon
1832
Stanley Black & Decker
SWK
$15.6B
-3,003
Closed -$487K
SWBI icon
1833
Smith & Wesson
SWBI
$658M
-4,522
Closed -$70K
SXT icon
1834
Sensient Technologies
SXT
$5.54B
-42
Closed -$2K
TBPH icon
1835
Theravance Biopharma
TBPH
$876M
-8,156
Closed -$120K
TCMD icon
1836
Tactile Systems Technology
TCMD
$676M
-846
Closed -$30K
TREX icon
1837
Trex
TREX
$5.05B
-29,953
Closed -$2.14M
TROX icon
1838
Tronox
TROX
$933M
-10,923
Closed -$85K
TRTX
1839
TPG RE Finance Trust
TRTX
$610M
-3,940
Closed -$33K
TTMI icon
1840
TTM Technologies
TTMI
$13.6B
-416,395
Closed -$4.75M
TWM icon
1841
ProShares UltraShort Russell2000
TWM
$41.7M
0
UAA icon
1842
Under Armour
UAA
$2.92B
-4,769
Closed -$53K
UEIC icon
1843
Universal Electronics
UEIC
$60.6M
-1,306
Closed -$49K
UHT
1844
Universal Health Realty Income Trust
UHT
$589M
-359
Closed -$20K
UVE icon
1845
Universal Insurance Holdings
UVE
$1.23B
-24,411
Closed -$337K
UVV icon
1846
Universal Corp
UVV
$1.3B
-932
Closed -$39K
VEON icon
1847
VEON
VEON
$3.78B
-573
Closed -$18K
VIR icon
1848
Vir Biotechnology
VIR
$1.54B
-242
Closed -$8K
VLGEA icon
1849
Village Super Market
VLGEA
$639M
-3,133
Closed -$77K
VNO icon
1850
Vornado Realty Trust
VNO
$7.45B
-37
Closed -$1K

Similar funds

Lazard Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.

  • Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
  • Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
  • Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
  • Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
  • Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
  • Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
  • Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.

Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.